cell Function & Pathophysiology Project
$184,136U24FY2012NSNIH
Mclean Hospital, Belmont MA
Investigators
Linked publications & trials
Paper 30595548Paper 29311330Paper 27641647Paper 27445146Paper 26839413Paper 24315443Paper 24148854Paper 23787135Paper 23666606Paper 22764206
Abstract
The Cell Function and Pathophysiology Core will be led by Dr. Ted Dawson and will function to determine disease-associated phenotypes from the differentiated PDiPS cell lines. In addition, the members of the Cell Function and Pathophysiology Core will be responsible for developing the existing phenotypic assays into a format amenable for large-scale drug screening. In conclusion, we think that the talented clinical investigators and translational scientists that comprise our current PDiPS Consortium are well placed to transition our groundbreaking work into a U24 format that meets the criteria outlined in the new RFA (RFA-NS-11-011, see Fig. 3 for Milestones).
View original record on NIH RePORTER →